中国康复理论与实践
中國康複理論與實踐
중국강복이론여실천
CHINESE JOURNAL OF REHABILITATION THEORY & PRACTICE
2015年
8期
894-899
,共6页
师伟%李晔紫%赵海滨%杨丹丹%姜天元%李东方%翟瑶瑶
師偉%李曄紫%趙海濱%楊丹丹%薑天元%李東方%翟瑤瑤
사위%리엽자%조해빈%양단단%강천원%리동방%적요요
急性心肌梗死%骨髓干细胞%血管内皮生长因子%微环境%活血化瘀法
急性心肌梗死%骨髓榦細胞%血管內皮生長因子%微環境%活血化瘀法
급성심기경사%골수간세포%혈관내피생장인자%미배경%활혈화어법
acute myocardial infarction%marrow stem cells%vascular endothelial growth factor%micro environment%Activating Blood to Resolve Stagnation method
目的:研究活血化瘀法对大鼠心肌组织微环境中CD34、血管内皮生长因子(VEGF)的影响,探讨其治疗急性心肌梗死的机制。方法 Sprague-Dawley大鼠32只随机分为假手术组(n=8)、模型组(n=8)、中药+粒细胞集落刺激因子(G-CSF)组(n=8)和G-CSF组(n=8)。各组均于造模3 h后给予相应药物,连续6 d,第7天处死取材。苏木素-伊红(HE)染色观察病理形态,免疫组化染色检测梗死心肌边缘区CD34、VEGF、Ki-67阳性细胞表达。结果模型组、中药+G-CSF组和G-CSF组CD34、VEGF、Ki-67阳性细胞表达均高于假手术组(P<0.05);中药+G-CSF组、G-CSF组高于模型组(P<0.05);中药+G-CSF组CD34、VEGF阳性表达高于G-CSF组(P<0.05),两组Ki-67阳性细胞表达无显著性差异(P>0.05)。结论活血化瘀法能够提高CD34和VEGF的表达,其作用优于单独使用G-CSF,可以有效治疗急性心肌梗死。
目的:研究活血化瘀法對大鼠心肌組織微環境中CD34、血管內皮生長因子(VEGF)的影響,探討其治療急性心肌梗死的機製。方法 Sprague-Dawley大鼠32隻隨機分為假手術組(n=8)、模型組(n=8)、中藥+粒細胞集落刺激因子(G-CSF)組(n=8)和G-CSF組(n=8)。各組均于造模3 h後給予相應藥物,連續6 d,第7天處死取材。囌木素-伊紅(HE)染色觀察病理形態,免疫組化染色檢測梗死心肌邊緣區CD34、VEGF、Ki-67暘性細胞錶達。結果模型組、中藥+G-CSF組和G-CSF組CD34、VEGF、Ki-67暘性細胞錶達均高于假手術組(P<0.05);中藥+G-CSF組、G-CSF組高于模型組(P<0.05);中藥+G-CSF組CD34、VEGF暘性錶達高于G-CSF組(P<0.05),兩組Ki-67暘性細胞錶達無顯著性差異(P>0.05)。結論活血化瘀法能夠提高CD34和VEGF的錶達,其作用優于單獨使用G-CSF,可以有效治療急性心肌梗死。
목적:연구활혈화어법대대서심기조직미배경중CD34、혈관내피생장인자(VEGF)적영향,탐토기치료급성심기경사적궤제。방법 Sprague-Dawley대서32지수궤분위가수술조(n=8)、모형조(n=8)、중약+립세포집락자격인자(G-CSF)조(n=8)화G-CSF조(n=8)。각조균우조모3 h후급여상응약물,련속6 d,제7천처사취재。소목소-이홍(HE)염색관찰병리형태,면역조화염색검측경사심기변연구CD34、VEGF、Ki-67양성세포표체。결과모형조、중약+G-CSF조화G-CSF조CD34、VEGF、Ki-67양성세포표체균고우가수술조(P<0.05);중약+G-CSF조、G-CSF조고우모형조(P<0.05);중약+G-CSF조CD34、VEGF양성표체고우G-CSF조(P<0.05),량조Ki-67양성세포표체무현저성차이(P>0.05)。결론활혈화어법능구제고CD34화VEGF적표체,기작용우우단독사용G-CSF,가이유효치료급성심기경사。
Objective To explore the effect of Activating Blood to Resolve Stagnation on the expression of CD34 and vascular endotheli-al growth factor (VEGF) in rats with acute myocardial infarction. Methods 32 Sprague-Dawley rats were randomly divided into sham opera-tion group (A, n=8), model group (B, n=8), Xuesaitong Injection + granulocyte colony-stimulating factor (G-CSF) group (C, n=8) and G-CSF group (D, n=8). Corresponding medicine was given to each group 3 hours after modeling, for 6 days. Pathomorphological changes were observed through HE staining, and the expression of CD34, VEGF and Ki-67 were observed through immunohistochemical staining. Re-sults The expressions of CD34, VEGF and Ki-67 were higher in groups B, C and D than in group A (P<0.05), and were higher in group groups C and D than in group B (P<0.05). The expressions of CD34 and VEGF were higher in group C than in group D (P<0.05). However, there was no significant difference in the expression of Ki-67 between 2 groups (P>0.05). Conclusion The expression of CD34 and VEGF in-creases with Activating Blood to Resolve Stagnation method, which is superior to using G-CSF only. Activating Blood to Resolve Stagna-tion may play an important role in the treatment of acute myocardial infarction.